Our Platforms
Explore how STCC's integrated platforms are driving translational cancer research forward by connecting expertise, resources, and collaborations across Singapore’s cancer research ecosystem.
STCC brings together Singapore’s cancer ecosystem through five interconnected platforms that span clinical trials, data and biospecimens, translational research, industry partnerships, and population health.
Rather than operating as standalone capabilities, these platforms are designed to work in synergy, connecting clinicians, researchers, healthcare institutions, industry partners and policymakers within a single collaborative framework.
Cancer Clinical Trials & Investigational Medicine Units
Clinical trials are essential to advancing cancer care. STCC accelerates the delivery of innovative oncology studies by providing end-to-end support across feasibility assessments, study start-up, regulatory approvals, contracting, project management and multi-site coordination.
By bringing together leading cancer centres, clinicians and industry partners, STCC streamlines trial execution, expands patient access to novel therapies, and fosters a collaborative research ecosystem that accelerates the translation of scientific discoveries into better treatments and outcomes for patients across Singapore.
Explore Cancer Trials Excellence
Cancer Databases & Tissue Banks
Clinical research depends on access to high-quality data, biospecimens and research resources. STCC's Cancer Databases and Tissue Banks programme brings together cancer data, tissue repositories and multimodal research assets into a secure, integrated ecosystem that enables translational research, precision medicine and AI-driven innovation.
By connecting healthcare institutions, researchers and industry partners through harmonised data standards and streamlined governance, the programme provides efficient access to clinical data, biospecimens, pathology, imaging and genomics resources. This accelerates scientific discovery, strengthens cross-institutional collaboration, supports the development of new diagnostics and therapies, and advances better outcomes for cancer patients while positioning Singapore as a global leader in oncology research.
Access Singapore's Cancer Database
Translational Research Integration & Support
STCC's Translational Research Integration and Support platform provides a seamless end-to-end pathway for cancer research, bringing together clinicians, researchers, industry partners and research institutions across Singapore. From study design, ethics approvals and project governance to patient cohort identification, biospecimen access, molecular profiling, data integration and advanced analytics, the platform serves as a single point of coordination for complex multi-institutional projects.
By combining dedicated project management with access to cutting-edge technologies and translational expertise, it accelerates biomarker discovery, clinical validation and research translation, enabling innovative diagnostics, precision therapies and meaningful improvements in patient outcomes.
Discover End-to-End Research Support
Business Intelligence & Development
Advancing cancer innovation requires strong partnerships across research, healthcare and industry. STCC's Industry Engagement and Partnerships programme serves as the gateway to Singapore's cancer research ecosystem, connecting global pharmaceutical, biotech, MedTech and diagnostics companies with leading clinicians, researchers and healthcare institutions.
Through strategic relationship-building, opportunity sourcing and collaboration development, the programme enables access to clinical expertise, patient populations, biospecimens, research capabilities and translational platforms across Singapore. By fostering cross-sector partnerships and facilitating clinical trials, translational research and innovation programmes, the platform accelerates the development of new diagnostics, therapies and healthcare solutions.
It provides industry partners with a streamlined entry point into Singapore's oncology landscape while helping researchers access funding, technologies and global networks, ultimately driving scientific breakthroughs and improving outcomes for cancer patients.
Unlock Collaboration Opportunities
Impact & Population Health
Effective cancer strategies depend on strong evidence to understand population needs, healthcare outcomes and the value of interventions. STCC's Impact and Population Health programme generates real-world insights from national cancer, healthcare and screening data to evaluate prevention strategies, care models, survivorship outcomes and healthcare utilisation across Singapore.
By bringing together expertise in population health, health economics, implementation science and outcomes research, the programme provides evidence that informs healthcare planning, guides resource allocation and supports value-based cancer care. Through collaborations with healthcare institutions, policymakers and researchers, it helps identify gaps in care, improve screening and prevention efforts, reduce disparities, and shape policies that ultimately deliver better outcomes for cancer patients and the wider community.
Discover Policy-Shaping Research